Hims & Hers CEO says FTC lawsuit misunderstands how the company works
Reported by CNBC · cnbc.com · August 18, 2026
Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.
What the tape says
What to watch: Hims & Hers Health Inc. (HIMS) faces a legal or regulatory issue — headline risk here is often larger than the eventual financial impact.
Market reaction today: $HIMS -7.99%
Tone and severity are deterministic keyword classification — not a prediction, a member vote, or a recommendation. Figures are extracted from the headline as published. Wook does not republish CNBC's reporting.
Your read
Discussion
No one has weighed in yet. Start the discussion on this story.
Headline and link are attributed to CNBC. Wook of Wall Street is an independent research tool and is not affiliated with CNBC. Nothing here is financial advice or a recommendation — research and educational content only.